Skip to content

The research of clinical application methodology of ZiCui Decoction in treating diabetic nephropathy

The research of clinical application methodology of ZiCui Decoction in treating diabetic nephropathy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OON-17012076
Enrollment
Unknown
Registered
2017-07-21
Start date
2017-07-21
Completion date
Unknown
Last updated
2017-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic nephropathy

Interventions

Cohort 1:ZiCui Decoction
Cohort 2:Huangkui capsule

Sponsors

Second affiliated Hospital of Tianjin University of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged 18 years old and more; 2. The diabetic nephropathy was diagnosed as stage III by clinical doctors; 3. Syndrome type is not limited; 4. Voluntarily signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Taking traditional Chinese medicine decoction or Chinese patent medicine at the same time; 2. Antibiotics and probiotics were used 30 days before the start of the trial; 3. Having serious heart, brain, blood vessel, liver, kidney, blood system disease, uremia patient; 4. There are diabetic ketoacidosis, hyperosmolar coma and other acute metabolic disorders within 1 month; 5. Not willing to cooperate and having the mentally ill; 6. Pregnancy, ready for pregnancy or lactation; 7. Allergic constitution.

Design outcomes

Primary

MeasureTime frame
Glu;GHb;Cr;u-ALB;U-pr;UCR;Routine blood test;UAER;GFR;u-ALB/UCR;Vital Signs;Height;Weight;BMI;Detection of intestinal flora;

Countries

China

Contacts

Public ContactYuhong Huang

Second affiliated Hospital of Tianjin University of TCM

hyh101@126.com+86 022-60335308

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026